3 recruiting, 2 active not recruiting, 1 completed. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 3, Active not recruiting 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Refractory Medulloblastoma: new trials by email Literature Review of Refractory Medulloblastoma trials Research Report on Refractory Medulloblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS) 25 mCi 177Lu- DTPA-omburtamab - Recurrent Medulloblastoma, Refractory Medulloblastoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 24 | 2026-07-02 | 2026-10-08 |
| GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults GPC2-CAR T cells, Fludarabine, Cyclophosphamide - Medulloblastoma, Central Nervous System Embryonal Tumor | Phase 1 | Recruiting | Stanford University | 18 | 2025-08-28 | 2026-10-09 |
| Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors LUTATHERA® (Lutetium Lu 177 dotatate) - High Grade Glioma, Meningioma | Phase 1 / Phase 2 | Recruiting | Nationwide Children's Hospital | 65 | 2022-11-21 | 2026-11-16 |
| Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors Biospecimen Collection, Magnetic Resonance Imaging, Savolitinib - Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Malignant Glioma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 41 | 2018-11-27 | 2026-07-30 |
| Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma Biospecimen Collection, Conventional Magnetic Resonance Imaging, Diffusion Tensor Imaging - Constitutional Mismatch Repair Deficiency Syndrome, Lynch Syndrome | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 71 | 2015-06-03 | 2026-07-20 |
| Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Adavosertib, Irinotecan Hydrochloride - Central Nervous System Embryonal Tumor With Rhabdoid Features, Central Nervous System Embryonal Tumor, Not Otherwise Specified | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 76 | 2014-03-28 | 2023-09-26 |
Medulloblastoma (6) · Central Nervous System Neoplasms (3) · Diffuse Intrinsic Pontine Glioma (3) · Glioma (3) · Brain Neoplasms (2) · Ependymoma (2) · Neuroectodermal Tumors, Primitive (2) · Pinealoma (2) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Familial ependymoma (1) · Meningioma (1) · Neoplasms, Germ Cell and Embryonal (1) · Neuroblastoma (1) · Rhabdoid Tumor (1) · Rhabdomyosarcoma (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Neoplasms, Nerve Tissue (6) · Neoplasms, Neuroepithelial (6) · Neuroectodermal Tumors (6) · Brain Diseases (5) · Central Nervous System Diseases (5) · Neoplasms by Site (5) · Neoplasms, Germ Cell and Embryonal (5) · Nervous System Diseases (5) · Nervous System Neoplasms (5) · Neuroectodermal Tumors, Primitive (4) · Brain Neoplasms (3) · Brain Stem Neoplasms (3)
Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine (1) · Cyclophosphamide (1) · Diffusion Tensor Imaging (1) · Irinotecan (1) · Phantoms, Imaging (1) · X-Rays (1) · adavosertib (1) · fludarabine (1) · lutetium Lu 177 dotatate (1) · pembrolizumab (1)
National Cancer Institute (NCI) (3) · Memorial Sloan Kettering Cancer Center (1) · Nationwide Children's Hospital (1) · Stanford University (1)
United States (6) · Canada (3)
Eugene I Hwang (1) · Katherine Ryan, DO (1) · Kristina A Cole (1) · Margot Lazow, MD (1) · Ralph Salloum (1) · Sameer Farouk Sait, MBBS (1)
UM1CA081457 (2), UM1CA097452 (1)